Investment Centers of America’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Investment Centers of America’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-4,642	Closed	-$219K	–	503
2015 Q3	$219K	Buy	+4,642	New	+$280K	0.03%	377

Other funds holding XPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

KHLMVGHM

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $1.53B AUM 20.88% 1-Year Est. Return

Investment Centers of America's XPH Position: Q4 2015 in Review

Investment Centers of America sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2015, closing a stake of 4,642 shares — an estimated $219K sold.

Investment Centers of America first reported a position in XPH in Q3 2015 and held it in 1 quarter. The position peaked at $219K in Q3 2015. 76 funds tracked by Wall St. Rank hold XPH as of Q4 2015.

Investment Centers of America reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2015 after selling out during the quarter.
Investment Centers of America sold 4,642 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2015, an estimated $219K.
Investment Centers of America first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2015 and held it in 1 quarter.
Investment Centers of America's State Street SPDR S&P Pharmaceuticals ETF position peaked at $219K in Q3 2015.
76 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2015.

Based on Investment Centers of America's 13F filing for Q4 2015, filed 16 Feb 2016.